Diego Serrano

1.1k total citations
25 papers, 750 citations indexed

About

Diego Serrano is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Diego Serrano has authored 25 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Diego Serrano's work include Lung Cancer Research Studies (6 papers), DNA Repair Mechanisms (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Diego Serrano is often cited by papers focused on Lung Cancer Research Studies (6 papers), DNA Repair Mechanisms (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Diego Serrano collaborates with scholars based in Spain, United States and Canada. Diego Serrano's co-authors include Alfonso Calvo, Jon Lecanda, Miriam Redrado, Raúl Catena, Damien D’Amours, Anne‐Marie Bleau, Víctor Segura, Jeffrey E. Green, Francisco Expósito and Norma B. Sterin‐Speziale and has published in prestigious journals such as Molecular Cell, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Diego Serrano

25 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Serrano Spain 15 410 278 159 138 136 25 750
Johanna Tuomela Finland 19 537 1.3× 327 1.2× 179 1.1× 188 1.4× 174 1.3× 49 984
Jinah Park South Korea 19 787 1.9× 262 0.9× 185 1.2× 112 0.8× 137 1.0× 32 1.1k
Nicholas Theodosakis United States 16 503 1.2× 346 1.2× 179 1.1× 124 0.9× 235 1.7× 35 930
Tina Gruosso Canada 12 587 1.4× 337 1.2× 420 2.6× 193 1.4× 121 0.9× 22 1.0k
Rika Tsuchida Japan 12 572 1.4× 310 1.1× 334 2.1× 88 0.6× 100 0.7× 16 902
Rezina Arju United States 11 617 1.5× 254 0.9× 168 1.1× 136 1.0× 92 0.7× 16 933
Renata Binato Brazil 19 532 1.3× 205 0.7× 168 1.1× 85 0.6× 68 0.5× 60 876
Sanjeevani Arora United States 13 451 1.1× 378 1.4× 208 1.3× 73 0.5× 131 1.0× 26 830
Chiara Bazzichetto Italy 14 402 1.0× 330 1.2× 162 1.0× 149 1.1× 111 0.8× 23 727
Atsuko Ashida Japan 11 330 0.8× 317 1.1× 139 0.9× 184 1.3× 53 0.4× 29 636

Countries citing papers authored by Diego Serrano

Since Specialization
Citations

This map shows the geographic impact of Diego Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Serrano more than expected).

Fields of papers citing papers by Diego Serrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Serrano. The network helps show where Diego Serrano may publish in the future.

Co-authorship network of co-authors of Diego Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Serrano. A scholar is included among the top collaborators of Diego Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Serrano. Diego Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castro, Flávia, Marta L. Pinto, Catarina Leite Pereira, et al.. (2025). Chitosan/γ-PGA nanoparticles and IFN-γ immunotherapy: A dual approach for triple-negative breast cancer treatment. Journal of Controlled Release. 379. 621–635. 10 indexed citations
2.
Arozarena, Imanol, Diego Serrano, Esther Redín, et al.. (2023). Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. Cancers. 15(12). 3076–3076. 11 indexed citations
3.
León, Sergio, et al.. (2023). Presence of Activated (Phosphorylated) STAT3 in Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases. International Journal of Molecular Sciences. 24(18). 14219–14219. 3 indexed citations
4.
Serrano, Diego, Noëlia Casares, Marta Gorraiz, et al.. (2022). Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells. Journal for ImmunoTherapy of Cancer. 10(8). e004479–e004479. 28 indexed citations
5.
Torres, Fernando, Aldo Ummarino, Esther Redín, et al.. (2022). Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists. Biomedicines. 10(7). 1590–1590. 15 indexed citations
6.
Redín, Esther, Eva M. Garrido‐Martín, Karmele Valencia, et al.. (2022). YES1 Is a Druggable Oncogenic Target in SCLC. Journal of Thoracic Oncology. 17(12). 1387–1403. 17 indexed citations
7.
Palanca-Ballester, Cora, Aitor Rodríguez‐Casanova, Susana Torres‐Martínez, et al.. (2021). Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers. 13(12). 3016–3016. 55 indexed citations
8.
Anfray, Clément, Francesco Mainini, Elisabeth Digifico, et al.. (2021). Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. Journal for ImmunoTherapy of Cancer. 9(9). e002408–e002408. 67 indexed citations
9.
Esteban, Emilio, Francisco Expósito, Guillermo Crespo, et al.. (2021). Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers. 13(11). 2849–2849. 13 indexed citations
10.
Serrano, Diego, et al.. (2020). Repeated stereotactic radiosurgery for recurrent brain metastases: An effective strategy to control intracranial oligometastatic disease. Critical Reviews in Oncology/Hematology. 153. 103028–103028. 10 indexed citations
11.
Serrano, Diego, Ryo Kawamura, Aleksandr Sverzhinsky, et al.. (2020). The Smc5/6 Core Complex Is a Structure-Specific DNA Binding and Compacting Machine. Molecular Cell. 80(6). 1025–1038.e5. 47 indexed citations
12.
Serrano, Diego, et al.. (2016). Centrosome-Dependent Bypass of the DNA Damage Checkpoint by the Polo Kinase Cdc5. Cell Reports. 14(6). 1422–1434. 15 indexed citations
13.
Serrano, Diego & Damien D’Amours. (2014). When genome integrity and cell cycle decisions collide: roles of polo kinases in cellular adaptation to DNA damage. PubMed. 8(3). 195–203. 19 indexed citations
14.
Fernandez‐Garcia, Ignacio, Arrate Muñoz‐Barrutia, Diego Serrano, et al.. (2012). Multiscalein situanalysis of the role of dyskerin in lung cancer cells. Integrative Biology. 5(2). 402–413. 13 indexed citations
15.
Bleau, Anne‐Marie, Miriam Redrado, Diego Serrano, et al.. (2012). Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144. Experimental Cell Research. 319(3). 12–22. 57 indexed citations
16.
Serrano, Diego, Anne‐Marie Bleau, Ignacio Fernandez‐Garcia, et al.. (2011). Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer. Molecular Cancer. 10(1). 96–96. 77 indexed citations
17.
Nguewa, Paul, Juan A. Díaz-González, Ernest Hamel, et al.. (2009). The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer. British Journal of Cancer. 100(6). 932–940. 42 indexed citations
18.
Lecanda, Jon, Jeffrey E. Green, Víctor Segura, et al.. (2009). VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop. Experimental Cell Research. 316(4). 554–567. 101 indexed citations
19.
Segura, Víctor, et al.. (2007). Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo. International Journal of Cancer. 121(6). 1197–1204. 9 indexed citations
20.
Serrano, Diego, et al.. (2002). Cell proliferation and morphometric changes in the rat kidney during postnatal development. Anatomy and Embryology. 205(5-6). 431–440. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna Tuomela Breakdown of academic impact, for papers by Jinah Park Breakdown of academic impact, for papers by Nicholas Theodosakis Breakdown of academic impact, for papers by Tina Gruosso Breakdown of academic impact, for papers by Rika Tsuchida Breakdown of academic impact, for papers by Rezina Arju Breakdown of academic impact, for papers by Renata Binato Breakdown of academic impact, for papers by Sanjeevani Arora Breakdown of academic impact, for papers by Chiara Bazzichetto Breakdown of academic impact, for papers by Atsuko Ashida
Rankless by CCL
2026